These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 565479)
1. The effect of manipulation of cholinergic mechanisms on turning behaviour in mice with unilateral destruction of the nigro-neostriatal dopaminergic system. Pycock C; Milson J; Tarsy D; Marsden CD Neuropharmacology; 1978 Mar; 17(3):175-83. PubMed ID: 565479 [No Abstract] [Full Text] [Related]
2. Effects of chronic morphine treatment on dopamine-mediated turning behaviour in rats and mice with 6-hydroxydopamine-induced unilateral nigro-striatal lesions. Slater P; Crossman AR Neuropharmacology; 1980 Mar; 19(3):289-95. PubMed ID: 7191487 [No Abstract] [Full Text] [Related]
3. Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviour. Fuxe K; Ungerstedt U Pharmacol Ther B; 1976; 2(1):41-7. PubMed ID: 817332 [No Abstract] [Full Text] [Related]
4. Stereotyped behaviour after cholinergic, but not dopaminergic, stimulation of the substantia nigra in rats. Decsi L; Nagy J; Zámbó K Life Sci; 1978 Jun; 22(21):1873-8. PubMed ID: 566832 [No Abstract] [Full Text] [Related]
5. Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA. Hefti F; Melamed E; Sahakian BJ; Wurtman RJ Pharmacol Biochem Behav; 1980 Feb; 12(2):185-8. PubMed ID: 7189592 [TBL] [Abstract][Full Text] [Related]
6. Ascorbate blocks amphetamine-induced turning behavior in rats with unilateral nigro-striatal lesions. Tolbert LC; Thomas TN; Middaugh LD; Zemp JW Brain Res Bull; 1979; 4(1):43-8. PubMed ID: 572739 [TBL] [Abstract][Full Text] [Related]
7. The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions. Fung YK; Uretsky NJ J Pharmacol Exp Ther; 1980 Sep; 214(3):651-6. PubMed ID: 6772760 [TBL] [Abstract][Full Text] [Related]
8. Dopamine-mediated circling behaviour does not involve the nigro-tectal pathway. Reavill C; Leigh N; Jenner P; Marsden CD Exp Brain Res; 1979 Oct; 37(2):309-16. PubMed ID: 315328 [TBL] [Abstract][Full Text] [Related]
9. Rotational behavior induced by unilateral electrical stimulations of nigro-striatal dopamine neurons: modification by low doses of apomorphine. Barghon R; Costentin JH Eur J Pharmacol; 1980 May; 64(1):39-46. PubMed ID: 6969658 [TBL] [Abstract][Full Text] [Related]
10. The effects of narcotic analgesics on the turning behaviour of rats with 6-hydroxydopamine-induced unilateral nigro-striatal lesions. Slater P; Blundell C; Crossman AR Neuropharmacology; 1980 Feb; 19(2):187-93. PubMed ID: 6102357 [No Abstract] [Full Text] [Related]
11. Rotational behaviour elicited by 5-HT in the rat: evidence for an inhibitory role of 5-HT in the substantia nigra and corpus striatum. James TA; Starr MS J Pharm Pharmacol; 1980 Mar; 32(3):196-200. PubMed ID: 6103936 [TBL] [Abstract][Full Text] [Related]
12. Neuroleptics: relation between cataleptic and anti-turning actions, and role of the cholinergic system. Muller P; Seeman P J Pharm Pharmacol; 1974 Dec; 26(12):981-4. PubMed ID: 4156868 [No Abstract] [Full Text] [Related]
13. Apomorphine stereotypies and transmitter mechanisms in the striatum. II. Interactions between GABA-ergic and cholinergic transmission. Georgiev VP; Petkova BP Acta Physiol Pharmacol Bulg; 1978; 4(3):65-70. PubMed ID: 220844 [TBL] [Abstract][Full Text] [Related]
14. The importance of calcium in amphetamine-induced turning behavior in mice with unilateral nigro-striatal lesions. Fung YK; Uretsky NJ Neuropharmacology; 1980 Jun; 19(6):555-60. PubMed ID: 6772983 [No Abstract] [Full Text] [Related]
15. Drug-induced rotation in rats without lesions: behavioral and neurochemical indices of a normal asymmetry in nigro-striatal function. Jerussi TP; Glick SD Psychopharmacology (Berl); 1976 Jun; 47(3):249-60. PubMed ID: 823560 [TBL] [Abstract][Full Text] [Related]
16. Apomorphine stereotypies and transmitter mechanisms in the striatum. I. Changes in the apomorphine stereotypies caused by drugs acting on the GABA-ergic, dopaminergic and cholinergic transmission. Georgiev VP; Markovska VL; Petkova BP Acta Physiol Pharmacol Bulg; 1978; 4(3):56-64. PubMed ID: 220843 [TBL] [Abstract][Full Text] [Related]
17. Operant control of turning in circles: a new model of dopaminergic drug action. Glick SD Brain Res; 1982 Aug; 245(2):394-7. PubMed ID: 6889903 [TBL] [Abstract][Full Text] [Related]
18. Proceedings: Differences in circling responses following electrolytic and 6-hydroxydopamine lesions of the nigro-striatal pathway. Costall B; Marsden CD; Naylor RJ; Pycock CJ Br J Pharmacol; 1975 Oct; 55(2):289P-290P. PubMed ID: 1238135 [No Abstract] [Full Text] [Related]
19. Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei. Wolfarth S Pol J Pharmacol Pharm; 1976; 28(5):469-93. PubMed ID: 796834 [No Abstract] [Full Text] [Related]
20. Substantia nigra as an out-put station for striatal dopaminergic responses: role of a GABA-mediated inhibition of pars reticulata neurons. Di Chiara G; Porceddu ML; Morelli M; Mulas ML; Gessa GL Naunyn Schmiedebergs Arch Pharmacol; 1979 Mar; 306(2):153-9. PubMed ID: 571967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]